Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-7,017
Closed -$414K – 4102
2026
Q1
$414K Buy
+7,017
New +$442K ﹤0.01% 2664
2025
Q3
– Sell
-21,623
Closed -$785K – 2805
2025
Q2
$785K Buy
21,623
+9,933
+85% +$276K ﹤0.01% 1381
2025
Q1
$256K Sell
11,690
-4,989
-30% -$124K ﹤0.01% 1859
2024
Q4
$404K Buy
+16,679
New +$368K ﹤0.01% 1556
2024
Q2
– Sell
-11,237
Closed -$400K – 2159
2024
Q1
$400K Buy
+11,237
New +$336K ﹤0.01% 1379
2023
Q4
– Sell
-14,988
Closed -$463K – 2266
2023
Q3
$463K Buy
14,988
+9,370
+167% +$324K ﹤0.01% 1446
2023
Q2
$224K Sell
5,618
-2,277
-29% -$82.8K ﹤0.01% 1783
2023
Q1
$305K Buy
+7,895
New +$313K ﹤0.01% 1705

Other funds holding ALNT

HRT Financial's ALNT Position: Q2 2026 in Review

HRT Financial sold out of Allient (ALNT) in Q2 2026, closing a stake of 7,017 shares — an estimated $414K sold.

HRT Financial first reported a position in ALNT in Q1 2023 and held it in 8 quarters. The position peaked at $785K in Q2 2025. 229 funds tracked by Wall St. Rank hold ALNT as of Q2 2026.

  • HRT Financial reported no remaining Allient position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 7,017 Allient shares in Q2 2026, an estimated $414K.
  • HRT Financial first reported a position in Allient in Q1 2023 and held it in 8 quarters.
  • HRT Financial's Allient position peaked at $785K in Q2 2025.
  • 229 funds tracked by Wall St. Rank held Allient as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.